Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Revenue (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Revenue for 6 consecutive years, with $62.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 9.01% year-over-year to $62.5 million, compared with a TTM value of $212.7 million through Dec 2025, up 1.59%, and an annual FY2025 reading of $212.7 million, up 1.59% over the prior year.
  • Revenue was $62.5 million for Q4 2025 at Treace Medical Concepts, up from $50.2 million in the prior quarter.
  • Across five years, Revenue topped out at $68.7 million in Q4 2024 and bottomed at $18.7 million in Q1 2021.
  • Average Revenue over 5 years is $42.3 million, with a median of $43.3 million recorded in 2023.
  • The sharpest move saw Revenue surged 166.88% in 2021, then decreased 9.01% in 2025.
  • Year by year, Revenue stood at $33.4 million in 2021, then soared by 48.84% to $49.8 million in 2022, then rose by 25.0% to $62.2 million in 2023, then rose by 10.44% to $68.7 million in 2024, then dropped by 9.01% to $62.5 million in 2025.
  • Business Quant data shows Revenue for TMCI at $62.5 million in Q4 2025, $50.2 million in Q3 2025, and $47.4 million in Q2 2025.